Hypertension & Arterial Disease: Foam Cell Formation Link
- London — New research illuminates how hypertension contributes to arterial disease.
- These foam cells are key components of plaque, which narrows and hardens arteries.
- "This finding is pivotal because VSMCs make up over half of the foam cells found in arterial blockages," said Professor iskratsch.
Uncover teh critical link between hypertension and arterial disease in this groundbreaking report. Researchers have identified how high blood pressure directly transforms artery muscle cells into dangerous “atherosclerosis-pathway-discovery/” title=”… Pathway Discovery”>foam cells,” the building blocks of arterial plaque. The study pinpoints the Piezo1 protein as a key player in this damaging process, a finding with serious implications for new therapies. This pivotal research,published in Advanced Science,is already setting the stage for innovative treatments. Understanding the cellular transformation provides a crucial blueprint for developing next-generation solutions. This information, fresh from the News Directory 3, illuminates the pathway to combating the life-threatening consequences of arterial disease. Future research is focused on targeting specific pressure-sensitive cell points, possibly preventing plaque buildup and revolutionizing arterial health. discovering ways to reverse this transformation could save millions of lives. Discover what’s next …
High Blood Pressure’s Role in Arterial disease Unveiled
Updated June 16, 2025
London — New research illuminates how hypertension contributes to arterial disease. The study, led by Professor Thomas Iskratsch at Queen Mary University of London, details how elevated blood pressure changes the role of muscle cells in artery walls, turning them into foam cells.
These foam cells are key components of plaque, which narrows and hardens arteries. The study, published in Advanced Science, focused on vascular smooth muscle cells (VSMCs), which are critical for maintaining blood vessel health. Researchers found that high pressure alone causes VSMCs to accumulate lipid droplets and transform into foam cells, leading to atherosclerotic lesions.
“This finding is pivotal because VSMCs make up over half of the foam cells found in arterial blockages,” said Professor iskratsch. “Understanding how pressure flips this switch from muscle to foam cell is crucial for developing new therapies to control or reverse the buildup of these hazardous lesions.”
The research identified a mechanosignaling pathway involving Piezo1, a pressure-sensitive protein.Changes in lipid metabolism and gene activity also play a role. These discoveries coudl lead to treatments targeting specific pressure-sensitive points within cells, potentially preventing or reducing arterial plaque.
“Our findings provide a vital blueprint for developing next-generation therapies that could benefit millions suffering from the life-threatening consequences of arterial disease,” concludes Professor Iskratsch. “This is a notable step forward in our journey towards a future where high blood pressure doesn’t have to steal away life.”
What’s next
Future research will focus on developing medications that target the identified mechanisms, aiming to prevent or shrink atherosclerotic lesions and mitigate the harmful effects of high blood pressure on arterial health.